Literature DB >> 11559789

Adenovirus vector designed for expression of toxic proteins.

D Edholm1, M Molin, E Bajak, G Akusjärvi.   

Abstract

To construct recombinant adenoviruses expressing biologically active proteins may be impossible, or result in a significant reduction in virus yield, if the protein expressed has an inhibitory effect on virus replication or cellular growth. To overcome this problem, we previously designed adenovirus vectors expressing foreign proteins from inducible promoters. However, during our work with a replication-deficient virus expressing the ASF/SF2 splicing factor from a progesterone antagonist-inducible gene cassette, we discovered that ASF/SF2 was expressed at a significant level in the 293 producer cell line, even in the absence of inducer. 293 cells code for adenovirus E1A and E1B proteins and thus support the growth of E1-deficient adenoviruses. Here we show that this background ASF/SF2 expression results from a low level of E1A-mediated transactivation of the basal promoter driving transgene expression. To overcome the problem of leaky expression, we reconstructed a novel gene cassette that combines an inducible promoter and a Lac repressor protein-based block to reduce transcriptional elongation. We show that this novel vector system dramatically reduced background transgene expression and therefore should be useful for the rescue and propagation of high-titer stocks of recombinant adenoviruses expressing toxic proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559789      PMCID: PMC114528          DOI: 10.1128/JVI.75.20.9579-9584.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

Review 1.  Mechanisms of viral activators.

Authors:  A J Berk; T G Boyer; A N Kapanidis; R H Ebright; N N Kobayashi; P J Horn; S M Sullivan; R Koop; M A Surby; S J Triezenberg
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1998

Review 2.  Adenovirus vectors for human gene therapy.

Authors:  M M Hitt; F L Graham
Journal:  Adv Virus Res       Date:  2000       Impact factor: 9.937

Review 3.  Cell receptors involved in adenovirus entry.

Authors:  G R Nemerow
Journal:  Virology       Date:  2000-08-15       Impact factor: 3.616

Review 4.  Human adenovirus vectors for gene transfer into mammalian cells.

Authors:  M M Hitt; C L Addison; F L Graham
Journal:  Adv Pharmacol       Date:  1997

5.  VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression.

Authors:  Y Yoshida; N Emi; H Hamada
Journal:  Biochem Biophys Res Commun       Date:  1997-03-17       Impact factor: 3.575

6.  Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.

Authors:  Y Yoshida; H Hamada
Journal:  Biochem Biophys Res Commun       Date:  1997-01-13       Impact factor: 3.575

7.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

8.  Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system.

Authors:  S Rubinchik; R Ding; A J Qiu; F Zhang; J Dong
Journal:  Gene Ther       Date:  2000-05       Impact factor: 5.250

9.  Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression.

Authors:  S X Hu; W Ji; Y Zhou; C Logothetis; H J Xu
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

10.  The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

Authors:  S K Petersen-Mahrt; C Estmer; C Ohrmalm; D A Matthews; W C Russell; G Akusjärvi
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

View more
  5 in total

1.  Cellular splicing and transcription regulatory protein p32 represses adenovirus major late transcription and causes hyperphosphorylation of RNA polymerase II.

Authors:  Christina Ohrmalm; Göran Akusjärvi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Radioprotective effect of heat shock protein 25 on submandibular glands of rats.

Authors:  Hae-June Lee; Yoon-Jin Lee; Hee-Chung Kwon; Sangwoo Bae; Sung-Ho Kim; Jung-Joon Min; Chul-Koo Cho; Yun-Sil Lee
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

3.  Lac-regulated system for generating adenovirus 5 vaccine vectors expressing cytolytic human immunodeficiency virus 1 genes.

Authors:  Chunxia Zhao; Charles Jefferson Crews; Cynthia A Derdeyn; Jerry L Blackwell
Journal:  J Virol Methods       Date:  2009-05-03       Impact factor: 2.014

4.  Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.

Authors:  Jason G D Gall; Alena Lizonova; Damodar EttyReddy; Duncan McVey; Mohammed Zuber; Imre Kovesdi; Barbara Aughtman; C Richter King; Douglas E Brough
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

5.  Imaging of viral thymidine kinase gene expression by replicating oncolytic adenovirus and prediction of therapeutic efficacy.

Authors:  Eun-Jung Kim; Ji Young Yoo; Young-Hwan Choi; Keun-Jae Ahn; Jong-Doo Lee; Chae-Ok Yun; Mijin Yun
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.